Institute of Translational Pharmacology, IFT-CNR, Institute of Cell Biology and Neurobiology, IBCN-CNR, Rome, Italy.
Department of Experimental Medicine, Sapienza University of Rome, Italy.
Riv Psichiatr. 2020 Jan-Feb;55(1):4-15. doi: 10.1708/3301.32713.
The nerve growth factor (NGF) belongs to a family of proteins named neurotrophins, consisting of NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), NT-4/5 and NT-6. NGF regulates a large number of physiological mechanisms that result in neurotrophic, metabotrophic and/or immunotrophic effects. Neurodegenerative diseases, including Alzheimer disease, psychiatric disorders (e.g. depression and schizophrenia) and brain parasitic infection have in common the effect of changing the brain levels of neurotrophins, in particular NGF. The contribution of both NGF and its receptor TrkA in such events and the recent promising results of NGF based therapies are here presented and discussed.
神经生长因子(NGF)属于神经营养因子家族的一种蛋白质,包括 NGF、脑源性神经营养因子(BDNF)、神经生长因子-3(NT-3)、NT-4/5 和 NT-6。NGF 调节大量生理机制,产生神经营养、代谢和/或免疫营养作用。神经退行性疾病,包括阿尔茨海默病、精神障碍(如抑郁症和精神分裂症)和脑部寄生虫感染,其共同点是改变神经营养因子,特别是 NGF 的大脑水平。本文介绍并讨论了 NGF 及其受体 TrkA 在这些事件中的作用,以及基于 NGF 的治疗方法的最新有希望的结果。